Nancy Ruffing-Graham

Title: Insights into the Innovations of Nancy Ruffing-Graham

Introduction

Nancy Ruffing-Graham is a notable inventor based in Santa Monica, California, with significant contributions to the field of biotechnology. She has made a remarkable impact through her innovative patent related to the human CC-chemokine receptor 4 (CCR4), which plays a vital role in various biological processes.

Latest Patents

Ruffing-Graham holds one patent titled "Anti-CCR4 antibodies and methods of use therefor." This patent describes an antibody or its functional fragment that binds to the CCR4 receptor and effectively blocks the binding of ligands to the receptor. The invention also outlines methods for inhibiting the interaction of cells bearing CCR4 with its ligands, expanding its application in research, therapeutic, prophylactic, and diagnostic methods.

Career Highlights

Nancy is affiliated with Millennium Pharmaceuticals Limited, a well-respected company in the biopharmaceutical industry, known for its commitment to innovation in drug development. Her role at Millennium has allowed her to research and develop groundbreaking products that address critical health issues.

Collaborations

In her career, Nancy has worked alongside esteemed colleagues, including Lijun Wu and David P. Andrew. Their collaborative efforts have proven invaluable in advancing their collective research initiatives and enhancing the understanding of CCR4-related mechanisms.

Conclusion

Nancy Ruffing-Graham's work exemplifies the vital intersection of innovation and healthcare. With her patent on Anti-CCR4 antibodies, she has contributed to a deeper understanding of the receptor's role in various biological functions, paving the way for potential advancements in therapeutic applications. Her dedication to research continues to influence the field significantly, marking her as an impactful inventor in the biotechnology sector.